AstraZeneca to acquire specialty drug maker Omthera
AstraZeneca plans to buy Omthera Pharmaceuticals, a Princeton, N.J.-based specialty pharmaceutical company focused on medications for dyslipidemia. Under the deal announced Tuesday, London-based AstraZeneca said it’s acquiring Omthera for $12.